Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8976 - 9000 of 14692 in total
Experimental
Matched Categories: … Xanthines and Adrenergics ... etamiphylline and adrenergics …
Experimental
Illicit
Experimental
A laxative that undergoes enterohepatic circulation. It may cause jaundice.
Investigational
Withdrawn
Matched Categories: … Alimentary Tract and Metabolism …
Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.
Experimental
N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. The proteins that N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide targets include cyclin-A2 and cyclin-dependent kinase 2.
Experimental
Matched Description: … The proteins that N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide targets include cyclin-A2 and
AKI-001 is an aurora kinase inhibitor.
Experimental
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
Investigational
Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive drug.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
AMG 108 was investigated for use as an antirheumatic agent.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Ditazole is a non-steroidal anti-inflammatory drug (NSAID). Ditazole's analgesic and antipyretic effects are similar to phenylbutazone. Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade name Ageroplas.
Experimental
Withdrawn
Matched Description: … Ditazole's analgesic and antipyretic effects are similar to phenylbutazone. ... Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade …
Matched Categories: … Blood and Blood Forming Organs …
Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
Investigational
Matched Description: … Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon Cancer, among others.
Investigational
Matched Description: … Trebananib is under investigation for the treatment of Ovarian Cancer, Peritoneal Cancer, and Fallopian ... Trebananib has been investigated for the treatment of Cancer, Oncology, Carcinoma, Metastases, and Colon …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Blosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis, Postmenopausal.
Investigational
Matched Description: … Blosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Abituzumab has been used in trials studying the treatment of Prostate Cancer Metastatic.
Investigational
Matched Categories: … Amino Acids, Peptides, and Proteins …
Monalizumab has been used in trials studying the treatment of Gynecologic Cancer, Chronic Lymphocytic Leukemia, and Squamous Cell Carcinoma of the Oral Cavity.
Investigational
Matched Description: … has been used in trials studying the treatment of Gynecologic Cancer, Chronic Lymphocytic Leukemia, and
Matched Categories: … Amino Acids, Peptides, and Proteins …
Displaying drugs 8976 - 9000 of 14692 in total